Bttx stock forecast.

Nov 3, 2023 · After registering a 9.59% upside in the latest session, Better Therapeutics Inc (BTTX) has traded red over the past five days. The stock hit a weekly high of 0.1766 this Thursday, 11/02/23, jumping 9.59% in its intraday price action. The 5-day price performance for the stock is -12.71%, and -50.34% over 30 days.

Bttx stock forecast. Things To Know About Bttx stock forecast.

Their BTTX share price targets range from $3.00 to $9.00. On average, they anticipate the company's share price to reach $6.00 in the next year. This suggests a possible upside of 3,131.0% from the stock's current price. View analysts price targets for BTTX or view top-rated stocks among Wall Street analysts.To put that in perspective, its daily average trading volume is closer to 182,000 shares. BTTX stock is up 38.9% as of Tuesday morning. Investors seeking out even more of the most recent stock ...Predictions of BTTX stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bit Digital share forecasts, stock quote and buy / sell signals below. According to present data Bit Digital's BTBT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Better Therapeutics Inc Follow Share $0.20 After Hours: $0.19 (2.86%) -0.0056 Closed: Nov 30, 5:12:17 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Tempest Therapeutics Inc $3.52 TPST5.56%...

SAN FRANCISCO, October 16, 2023--Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced the ...

The consensus price target of analysts on Wall Street is $6.00, which implies an increase of 97.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.00 and $9.00 respectively. As a result, BTTX is trading at a discount of -5525.0% off the target high and -1775.0% off the low.Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00.BriaCell Therapeutics Corp - New Stock Forecast, BCTX stock price prediction. Price target in 14 days: 5.371 USD. The best long-term & short-term BriaCell ...The average Nokia stock price prediction forecasts a potential upside of 61.29% from the current NOK share price of $3.48. What is NOK's forecast return on equity (ROE) for 2023-2025? (NYSE: NOK) forecast ROE is N/A, which is considered weak.Nov 30, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Better Therapeutics stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BTTX. The average twelve-month price prediction for Better Therapeutics is $6.00 with a high price target of $9.00 and a low price target of $3.00.

What this means: InvestorsObserver gives Better Therapeutics Inc (BTTX) an overall rank of 34, which is below average. Better Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Earnings Summary. For their last quarter, Better Therapeutics (BTTX) reported earnings of -$0.15 per share. This reflects a breakeven earnings surprise. Look out for BTTX's next earnings release ...

The average Coupang stock price prediction forecasts a potential upside of 39.24% from the current CPNG share price of $15.80. What is CPNG's forecast return on equity (ROE) for 2023-2025? (NYSE: CPNG) forecast ROE is N/A, which is considered weak.Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics ...The 12-month stock price forecast is $27.25, which is an increase of 1,380.98% from the latest price. Price Target. $27.25 (1,380.98% upside) Analyst Consensus: Buy. Stock Forecasts. ... BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT) The most oversold stocks in the health care sector presents an opportunity to buy into …What this means: InvestorsObserver gives Better Therapeutics Inc (BTTX) an overall rank of 34, which is below average. Better Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system. BTTX’s last price was a discount, traded about -666.67% off its 52-week high of $1.61. The share price had its 52-week low at $0.14, which suggests the last value was 33.33% up since then. When we look at Better Therapeutics Inc’s average trading volume, we note the 10-day average is 1.42 million shares, with the 3-month average coming to 1 ...

27 Jun 2022 ... Combined with the massive total addressable market, BTTX appears to be one of the most viable penny stocks available. ... price of 61 cents. As ...AVDL Stock 12 Months Forecast. $21.00. (94.44% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Avadel Pharmaceuticals in the last 3 months. The average price target is $21.00 with a high forecast of $26.00 and a low forecast of $17.00. The average price target represents a 94.44% change from the last price of $10.80.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.The average twelve-month price prediction for Better Therapeutics is $6.00 with a high price target of $9.00 and a low price target of $3.00. Learn more on BTTX's analyst rating history. Do Wall Street analysts like Better Therapeutics more than its competitors?Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTXView the latest Better Therapeutics Inc. (BTTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Get the latest BTTX stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings date, dividend and more for BTTX, a biotechnology company developing treatments for neurological disorders.

Year to date, shares of BTTX have lost 67.7%. BTTX’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 24.22%. 7 Best Stocks for the Next 30 DaysStock Price Forecast. The 13 analysts offering 12-month price forecasts for Northern Oil and Gas Inc have a median target of 51.00, with a high estimate of 60.00 and a low estimate of 44.00. The ...Get the latest BTTX stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings date, dividend and more for BTTX, a biotechnology company developing treatments for neurological disorders. Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyUS stocks currently trading like hotcakes These stocks are more popular than Britney right now, having the highest trading volumes on the US stock market. Huge volumes tend to appear in tandem with strong price levels and pivot points, and are often the result of a large number of orders being filled on certain price levels, when big players ...Stock Price Forecast. The 13 analysts offering 12-month price forecasts for Northern Oil and Gas Inc have a median target of 51.00, with a high estimate of 60.00 and a low estimate of 44.00. The ...Dec 1, 2023 · Stock Price Forecast. According to 1 stock analyst, the 12-month stock price forecast for ACXP stock stock is $13, which predicts an increase of 246.67%. On average, analysts rate ACXP stock stock as a strong buy.

Stock Price Forecast. The 13 analysts offering 12-month price forecasts for Northern Oil and Gas Inc have a median target of 51.00, with a high estimate of 60.00 and a low estimate of 44.00. The ...

The 2 analysts offering 1 year price forecasts for BTTX have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to BTTX in the past 3 months.

The Better Therapeutics, Inc. stock forecast for tomorrow is $ 0.223794, which would represent a 15.18% gain compared to the current price. In the next week, the price of BTTX is expected to increase by 24.54% and hit $ 0.241978. As far as the long-term Better Therapeutics, Inc. stock forecast ...Dec 1, 2023 · Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022 Conference Call and Provide Business Update. STATEN ISLAND, N.Y. , Nov. 1, 2022 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibioti... Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyBetter Therapeutics Inc (NASDAQ:BTTX) trade information. Instantly BTTX has been showing red trend so far today with a performance of -9.01% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2280 on Monday, 11/27/23 increased the stock’s daily price by 21.05%.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bit Digital share forecasts, stock quote and buy / sell signals below. According to present data Bit Digital's BTBT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".View the latest BTTX earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine.Get the latest Better Therapeutics Inc (BTTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Find the latest Financials data for Better Therapeutics, Inc. Common Stock (BTTX) at Nasdaq.com.Better Therapeutics (BTTX) Stock Forecast & Price Prediction. Estimation of the future price movement of Better Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.Join this channel to get access to perks:https://www.youtube.com/channel/UCQvSqObd4nnhUWRm7fkRiRA/join-----...Aug 10, 2023 · High Growth Earnings: BTTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market : BTTX's revenue (68.3% per year) is forecast to grow faster than the US market (7.8% per year).

2 days ago · The latest Mountain Crest Acquisition stock prices, stock quotes, news, and BTTX history to help you invest and trade smarter. ... The 7 analysts offering price forecasts for Mountain Crest ... Nov 25, 2023 · After registering a 3.29% upside in the last session, Better Therapeutics Inc (BTTX) has traded red over the past five days. The stock hit a weekly high of 0.2280 this Friday, 11/24/23, jumping 3.29% in its intraday price action. The 5-day price performance for the stock is 20.07%, and 12.71% over 30 days. Find the latest Enovix Corporation (ENVX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Instagram:https://instagram. defense contractors stocksclearbridge dividend strategybest free expense report appstock block Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25. The ...Better Therapeutics Inc Forecast, Short-Term " BTTX" Stock Price Prognosis for Next Days Walletinvestor.com BTTX Forecast, Long-Term Price Predictions for Next Months and Year: 2023, 2024 axcellisfidelity select semiconductors portfolio Find the latest Vortex Brands Co. (VTXB) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ... nc dental insurance Find the latest Star Equity Holdings, Inc. (STRR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Aurora Cannabis Inc have a median target of 0.58, with a high estimate of 1.00 and a low estimate of 0.44. The median ...